Skip to content
lifestyle.newsblaze.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer
October 26, 2026
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
October 16, 2026
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
September 30, 2026
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
August 25, 2026
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
August 17, 2026